Abstract
Purpose
The intestinal organism Oxalobacter formigenes is unique in using oxalate as its primary carbon and energy source. Intestinal colonization with O. formigenes may have clinical significance by decreasing intestinal oxalate and its absorption, thereby influencing the concentration of oxalate in plasma and urine, and the development of calcium oxalate stone disease. Because the oxalate content of the diet varies considerably, we hypothesized that the number of O. formigenes and amount of oxalate would vary in feces.
Materials and Methods
To enumerate the number of O. formigenes in feces an accurate and reproducible real-time polymerase chain reaction assay was developed to quantify O. formigenes DNA. Stool samples were obtained from 10 colonized individuals to determine the levels of O. formigenes by this assay and the oxalate content by ion chromatography.
Results
Concentrations of O. formigenes ranged from lower than the limit of detection of 5 × 103 to 1.04 × 109 cells per gm stool. The total oxalate content of stool samples varied from 0.1 to 1.8 mg/gm and fecal water oxalate varied from 60 to 600 μM. All parameters measured varied within each stool collection, among stool collections on different days and among individuals. Notably in 7 of 10 individuals at least 1 stool sample contained no detectable O. formigenes. In addition, 7 of 10 subjects had a fecal colonization of less than 4 × 104 per gm stool.
Conclusions
This study demonstrates that there is intrastool and interstool sample variability in the amount of O. formigenes measured by real-time polymerase chain reaction that did not correlate with the quantity of oxalate in stool. Most subjects had a fecal colonization of less than 4 × 104 per gm stool.
Keywords: kidney, kidney calculi, Oxalobacter formigenes, calcium oxalate, intestines
Oxalobacter formigenes is a specialized anaerobic organism that can colonize the human large intestine. It is a specialist since it uses oxalate as its main carbon and energy source.1,2 It relies primarily on oxalate ingestion by the host for survival, although it is possible that small amounts of oxalate secreted from the body into the intestine help sustain colonization.3 It was hypothesized that intestinal colonization with this organism has clinical significance because it may limit intestinal oxalate absorption and under certain conditions it may promote the secretion of oxalate into the gut.4–6
We estimated that the mean oxalate intake is approximately 150 mg per day but there is a wide range due to the variety and quantity of foods eaten, and variability in the oxalate content of foods.7 A possible repercussion is that intestinal contents and feces also vary in their levels of O. formigenes and oxalate. There is some evidence that the number of O. formigenes in feces can be influenced by dietary oxalate. Doane et al reported that fecal levels of O. formigenes in colonized individuals increased 5 to 14-fold when the diet was supplemented with a quantity of spinach containing 1,500 mg oxalate.8
The number of O. formigenes organisms in feces was previously assessed by measuring cleared zones in defined agar medium containing calcium oxalate crystals.1 The reported range using this approach was 3 × 105 to 3 × 108 cells per gm feces.8,9 A quantitative PCR technique using a competitive DNA template for enumerating O. formigenes was previously described.10 In this study we developed a real-time PCR procedure for quantifying O. formigenes. We examined the variability of oxalate and number of O. formigenes within and between stool samples from 10 colonized individuals. This technique is more accurate and less time-consuming than the competitive PCR procedure.
MATERIALS AND METHODS
Subjects
Potential subjects who denied the current presence or a history of any disease that may affect intestinal function, hepatic metabolism or renal function were screened for participation in the study, which was approved by the institutional review board. For screening purposes each provided a stool sample to test for colonization with O. formigenes by conventional PCR.11 Ten healthy, adult nonkidney stone formers colonized with O. formigenes, including 7 males and 3 females with a mean ± SD age of 29 ± 4 years, were recruited for study. None of the subjects had received antibiotics or probiotic preparations in the 6 months before enrollment.
Samples
Participants provided fecal samples within 4 hours of passage for 5 consecutive days. Three 200 mg aliquots were taken from 3 regions of each stool sample and processed immediately. They were initially centrifuged at 16,100 × gravity for 20 minutes at room temperature to obtain a 5 to 10 μl fecal water sample. DNA was extracted from the remaining sample using a Qiagen™ DNA Stool Kit. After adding lysis buffer and heating the suspension for 5 minutes at 70C a 50 μl fecal homogenate sample was taken for total oxalate analysis. DNA extracted was quantified using a Beckman™ DU 640i spectrophotometer.
Oxalate Analysis
Fecal water and fecal homogenate samples were acidified below pH 1 with ultra pure hydrochloric acid (Fluka, Buchs, Switzerland) before storage at −70C. Before oxalate analysis fecal samples were diluted 100 to 500-fold in distilled water, followed by centrifugation at 16,100 × gravity for 20 minutes at room temperature. Oxalate in fecal samples was determined by ion chromatography (Dionex, Sunnyvale, California) with suppressed conductivity detection. Ion chromatography equipment consisted of a ED50 conductivity detector, GP50 gradient pump, AS50 autosampler, ASRS-ULTRA 2 mm suppressor (Dionex) and IonPac® AS4A-SC 2 × 250 mm ion exchange column with guard column. Oxalate was baseline separated from other anions using 0.7 mM carbonate/1.7 mM bicarbonate at a flow rate of 0.5 ml per minute.
Primers
Primers were developed using SeqWeb 2.1 (Accelrys®), which amplified a 164 bp sequence of the oxalyl coenzyme A decarboxylase (Oxc) gene. The specificity of these primers was confirmed by examining their homology with all other bacterial sequences deposited at the National Center for Biotechnology Information gene BLAST website (http://www.ncbi.nlm.nih.gov/BLAST). The forward primer consisted of 21 nucleotides with the sequence CGACAATGTAGAGTT-GACTGA (GC content 42.8% and melting temperature 59.5C). This included a 17 bp overlap with the forward primer used by Sidhu et al.10 The reverse primer, consisting of 19 nucleotides, was CGTGTTGTTCGTGACGAA (GC content 52.6% and melting temperature 60.5C).
PCR
Real-time PCR was performed using the DNA Engine Opticon® 2, version 2.02. All reactions were performed in 8 Low Tube Strips and closed with Flat Cap Strips (Bio-Rad™). PCR mixture (50 μl) contained 25 μl 2 × QuantiTect® SYBR® Green PCR Master Mix, forward and reverse primers, each at a final concentration of 0.25 μM, and 100 ng template DNA. Bovine serum albumin was added at 0.1 μg/μl to enhance PCR robustness. Uracil-N-glycosylase was added at 0.5 U per reaction to eliminate any deoxyuridine monophosphate containing products, which may result from carryover contamination. Optimization resulted in real-time cycling conditions of 50C for 2 minutes (carryover prevention) and 95C for 15 minutes (PCR initial activation step), followed by 45 cycles of denaturation at 94C for 15 seconds, annealing at 57C for 30 seconds and extension at 72C for 30 seconds. Each cycle was completed with melting peak analysis (55C to 95C) to confirm amplicon specificity and the lack of mispriming products, including primer dimers. An NTC and standards were included in each plate. If the NTC was positive, data were discarded and the reaction was repeated until the NTC was negative. A threshold line was drawn as low as possible above the noninformative fluorescent noise band, enabling the production of a standard curve with a correlation coefficient close to 1.12
For conventional PCR AccuPrime™ SuperMix I was used according to manufacturer instructions with the same primers as for real-time PCR. PCR cycling conditions consisted of initial denaturation at 94C for 2 minutes, followed by 35 cycles of denaturation at 94C for 30 seconds, annealing at 55C for 30 seconds and extension at 72C for 30 seconds. Amplification products were analyzed by agarose gel electrophoresis.
Standard Curves
O. formigenes, strain HC-1 (OxThera, Gainesville, Florida) was grown overnight at 37C in Medium B.1 Cells were counted by flow cytometry using a B-7277 Bacterial Counting Kit (Molecular Probes™). Cells were also harvested by centrifugation and DNA extracted using a Qiagen DNA Extraction Kit, permitting the calculation of the DNA content per cell.
RESULTS
As determined by flow cytometry, the average number of cells present was 8.6 ± 1.4 × 108/ml. The linear dynamic range of the real-time PCR assay was determined by serial dilution of O. formigenes DNA extracted from overnight cultures. Figure 1 shows the relationship of the number of O.formigenes to Ct. The assay was found to be linear over a 5 log10 range with a limit of detection of 5 cells or 5 × 103 cells per gm stool. Assay precision was tested by repetitive analysis of stool containing 2.2 × 104 O. formigenes per gm in 6 preparations. The intra-assay coefficient of variation was 1.3% for Ct and 14% for the number of bacteria enumerated. Method accuracy was tested by spiking stool that was negative for O. formigenes by culture and PCR tests (fig. 2). Mean recovery was 96% to 110% of the DNA added. Assay specificity was confirmed using DNA (American Type Culture Collection, Manassas, Virginia) isolated from organisms reported to degrade oxalate, including Acinetobacter species, Bacillus subtilis, Bifidobacterium breve, B. infantis, Enterococcus faecalis, Lactobacillus acidophilus and Providencia stuartii, and those not known to degrade oxalate, including Clostridium perfringens, Escherichia coli, Eubacterium limosum, Klebsiella pneumoniae and Pseudomonas aeruginosa.
Fig. 1.
Standard curve of number of O. formigenes in samples vs Ct. Curve was generated by serial dilution of DNA extracted from O. formigenes culture, in which cell numbers were estimated by flow cytometry and DNA quantified using spectrophotometer (1 ng DNA = 4.82 × 105 cells).
Fig. 2.
Recovery of O. formigenes DNA added to fecal samples from noncolonized individual. Recovery rate was 96% to 110%. Dashed line represents complete recovery. Solid line represents experimental results.
The effect of storage at different temperatures on the stool content of O. formigenes DNA was examined. After 24 hours at room temperature O. formigenes DNA recovered from 3 different sites slightly increased from 73.5 ± 9.5 to 105.5 ± 16.0 ng/200 mg stool. After 24 hours on ice it was essentially unchanged at 68.1 ± 8.1 ng/200 mg stool.
This real-time PCR assay was used to quantitate O. formigenes levels in a total of 146 stool aliquots from 49 fecal collections from 10 subjects. The table shows the quantification of O. formigenes in stool samples. All stool aliquots were positive in subjects 1, 3 and 8. Only 42 of the 107 stool aliquots (38%) from the remaining 7 individuals (subjects 2, 4 to 7, 9 and 10) contained detectable levels of O. formigenes. Subject 5 did not have any O. formigenes detected. Reeval uation of the screening sample using the real-time PCR technique demonstrated that colonization was at the lower limit of detection (5 × 103 cells per gm stool).
Figure 3 shows changes in O. formigenes and stool oxalate during 5 days in the 4 individuals with the most consistent colonization. Subjects 1 and 3 had high colonization with levels of 3.81 × 106 to 1.04 × 109 cells per gm stool. Subject 2 had low to moderate colonization with levels of no detectable O. formigenes (less than 5 × 103 cells per gm) to 2 × 106 cells per gm stool. Subject 4 consistently shed low levels of O. formigenes in stool samples with 1 of the 15 samples containing no detectable O. formigenes.
Fig. 3.
O. formigenes, total oxalate and fecal water oxalate in stool samples collected from subjects 1 to 4 (A to D) during 5 days. Bars represent mean with range determined in 3 samples from different sites of same stool sample. LOD, limit of detection.
The total oxalate content of stool samples was 0.1 to 1.8 mg/gm and the fecal water oxalate content was 50 to 630 μM. On regression analysis there were no significant correlations between O. formigenes levels and total stool or fecal water oxalate (p = 0.10 and 0.83, respectively).
DISCUSSION
The real-time PCR assay that we developed permitted determination of the levels of O. formigenes and its distribution within stool. This technique was used to quantify the levels of a large variety of organisms and it has advantages over other methods of detection.13 For example, the medium for the roll tube technique is not commercially available and colonies require 10 to 14 days to develop. The real-time PCR technique is rapid, requiring less than 1 day. In addition, it is precise based on an intravariability coefficient of variation of 1.3% for Ct and 14% for the number of bacteria enumerated, accurate based on the recovery of 96% to 110% of O. formigenes DNA added to an O. formigenes negative stool and specific based on our bacterial panel testing.
The stability of O. formigenes DNA was also established. Samples could be returned to the laboratory within 24 hours of passage without the loss of O. formigenes DNA. This stability is supported by a report of the maintenance of oxalate degradation rates in stool samples stored under similar conditions.9
We also observed variability in the O. formigenes content of stool samples among individuals and in stool samples obtained from the same individual on different days. O. formigenes levels varied 3 to 40,000-fold between individuals and 2 to 1,000-fold within individuals. We also detected variability of O. formigenes content in the same stool sample. These results are consistent with the nonuniform distribution of organisms in fecal samples that was previously recognized in swine.14,15
Lower levels of colonization were detected in this study compared to those in previous reports. The lowest levels reported by Allison9 and Doane8 et al were 4 × 106 organisms per gm, while most subjects in this study had lower levels. We recognize that this disparity could be due to differences in the populations assessed, dietary differences and the quantification techniques used.
These results also indicate that there is a significant chance of not detecting O. formigenes in stool specimens of colonized individuals. The organism was detected in all stool samples in only 3 subjects in this study. These results suggest that large or frequent samples of stool must be assayed to confirm the colonization status in some individuals or a pre-sample strategy should be developed to expand the stool number of O. formigenes. The ingestion of an oxalate rich food 1 to 2 days before testing is 1 such possible strategy. Support for this approach was provided by Doane et al, who reported that after 2-week equilibration on a spinach containing diet (1,570 mg oxalate per day) O. formigenes fecal levels increased 5 to 14-fold over baseline (100 mg oxalate per day).8
A number of factors may be responsible for the variable elimination of this bacterium in stool and the lack of correlation with stool oxalate. These factors include the soluble oxalate concentration near the mucosal wall where O. formigenes colonies may reside, the amount of oxalate in the diet, the bioavailability of food derived oxalate, unfavorable environmental conditions, including pH, the presence of formate or other growth inhibitory intestinal components and the inhibitory properties of other organisms. An additional factor that could contribute to the lack of a correlation of O. formigenes levels with stool oxalate is the presence of other fecal organisms that can degrade oxalate, including lactic acid bacteria.16
This research has potential clinical implications due to the possible effects of intestinal O. formigenes levels on oxalate handling in the body. Subjects with calcium oxalate stone disease colonized with O. formigenes were reported to have a lower urinary oxalate excretion than that of noncolonized stone formers.17,18 Increased urinary oxalate excretion is a risk factor for the formation of such stones. Experiments in animal models also support a role for O. formigenes for decreasing urinary oxalate excretion following colonization with O. formigenes or its daily administration.6,19 Colonization with O. formigenes may promote intestinal oxalate secretion and it is a potential therapeutic secretory route for oxalate in hyperoxalemic disorders, such as primary hyperoxaluria.4,5
The exact role that an accurate enumeration of O. formigenes in stool samples would have in the clinical management of stones is unclear at this time. However, the enumeration of O. formigenes may be important for defining the relationships among intestinal levels of O. formigenes, dietary oxalate, fecal oxalate, other intestinal flora and intestinal oxalate absorption. Such investigations should include the study of individuals consuming diets controlled in oxalate, calcium and other nutrients to clarify these relationships. When these relationships have been defined, it will be possible to determine whether colonization with O. formigenes has a role in the development of stone disease.
Table 1.
Quantification of O. formigenes DNA by real-time PCR from stool samples of 10 individuals for 5 days
Subject No. | % Pos Fecal Aliquots* | Mean O. Formigenes Cells/gm Stool (range) |
---|---|---|
1 | 100 | 2.12 × 108 (4.93 × 106–1.04 × 109) |
2 | 87 | 2.56 × 105 (less than 5 × 103–1.94 × 106) |
3 | 100 | 7.15 × 107 (3.81 × 106–1.84 × 108) |
4 | 93 | 1.23 × 104 (less than 5 × 103–4.16 × 104) |
5 | 0 | less than 5 × 103 |
6 | 27 | 5.80 × 103 (less than 5 × 103–1.7 × 104) |
7 | 20 | 6.05 × 103 (less than 5 × 103–2.08 × 104) |
8 | 100 | 5.84 × 103 (5 × 103–1.21 × 104) |
9 | 7 | 5.02 × 103 (less than 5 × 103–5.3 × 103) |
10 | 33 | 5.20 × 103 (less than 5 × 103–6.84 × 103) |
Each subject provided 1 fecal sample per day and 3 aliquots from different regions of each stool were assayed.
Greater than limit of detection of 5 × 103 cells per gm stool.
Acknowledgments
Dr. Harmeet Sidhu, Oxthera supplied the HC-1 strain of Oxalobacter formigenes. Martha Kennedy provided technical assistance.
Supported by National Institutes of Health Grant DK-62284.
Abbreviations and Acronyms
- Ct
threshold cycle
- NTC
no template control
- PCR
polymerase chain reaction
Footnotes
Study received institution review board approval.
References
- 1.Allison MJ, Dawson KA, Mayberry WR, Foss JG. Oxalobacter formigenes gen. nov., sp nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol. 1985;141:1. doi: 10.1007/BF00446731. [DOI] [PubMed] [Google Scholar]
- 2.Allison MJ, Daniel SL, Cornick NA. Oxalate Degrading Bacteria. Boca Raton: CRC Press; 1995. pp. 131–168. [Google Scholar]
- 3.Freel RW, Hatch M, Green M, Soleimani M. Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null mice. Am J Physiol. 2006;290:G719. doi: 10.1152/ajpgi.00481.2005. [DOI] [PubMed] [Google Scholar]
- 4.Hatch M, Cornelius J, Allison M, Sidhu H, Peck A, Freel RW. Oxalobacter sp reduces urinary oxalate excretion by promoting enteric oxalate secretion. Kid Int. 2006;69:691. doi: 10.1038/sj.ki.5000162. [DOI] [PubMed] [Google Scholar]
- 5.Hoppe B, Beck B, Gatter N, von Unruh G, Tischer A, Hesse A, et al. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kid Int. 2006;70:1305. doi: 10.1038/sj.ki.5001707. [DOI] [PubMed] [Google Scholar]
- 6.Sidhu H, Schmidt ME, Cornelius TJG, Thamiselvam S, Khan SR, Hesse A, et al. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol. 1999;10:S334. [PubMed] [Google Scholar]
- 7.Holmes RP, Kennedy M. Estimation of the oxalate content of foods and daily oxalate intake. Kid Int. 2000;57:1662. doi: 10.1046/j.1523-1755.2000.00010.x. [DOI] [PubMed] [Google Scholar]
- 8.Doane LT, Liebman M, Caldwell DR. Microbial oxalate degradation: effects on oxalate and calcium balance in humans. Nutr Res. 1989;9:957. [Google Scholar]
- 9.Allison MJ, Cook HM, Milne DB, Gallagher S, Clayman RV. Oxalate degradation by gastrointestinal bacteria from humans. J Nutr. 1986;116:455. doi: 10.1093/jn/116.3.455. [DOI] [PubMed] [Google Scholar]
- 10.Sidhu H, Allison M, Peck AB. Identification and classification of Oxalobacter formigines strains by using oligonucleotide probes and primers. J Clin Microbiol. 1997;35:350. doi: 10.1128/jcm.35.2.350-353.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Sidhu H, Holmes RP, Allison MJ, Peck AB. Direct quantification of the enteric bacterium Oxalobacter formigenes in human fecal samples by quantitative competitive-template PCR. J Clin Microbiol. 1999;37:1503. doi: 10.1128/jcm.37.5.1503-1509.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Larionov A, Krause A, Miller W. A standard curve based method for relative real time PCR data processing. BMC Bioinformatics. 2005;6:62. doi: 10.1186/1471-2105-6-62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Sails AD. Applications of real-time PCR in clinical microbiology. In: Edwards K, Logan J, Saunders N, editors. Real-Time PCR An Essential Guide. Norfolk: Horizon Bioscience; 2004. pp. 247–326. [Google Scholar]
- 14.Allison MJ, Robinson IM, Bucklin JA, Booth GD. Comparison of bacterial populations of the pig cecum and colon based upon enumeration with specific energy sources. Appl Environ Microbiol. 1979;37:1142. doi: 10.1128/aem.37.6.1142-1151.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Rall GD, Wood AJ, Wescott RB, Dommert AR. Distribution of bacteria in feces of swine. Appl Microbiol. 1970;20:789. doi: 10.1128/am.20.5.789-792.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Weese JS, Weese HE, Yuricek L, Rousseau J. Oxalate degradation by intestinal lactic acid bacteria in dogs and cats. Vet Microbiol. 2004;101:161. doi: 10.1016/j.vetmic.2004.03.017. [DOI] [PubMed] [Google Scholar]
- 17.Kwak C, Kim HK, Kim EC, Choi MS, Kim HH. Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol. 2003;44:475. doi: 10.1016/s0302-2838(03)00318-x. [DOI] [PubMed] [Google Scholar]
- 18.Troxel SA, Sidhu H, Kaul P, Low RK. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol. 2003;17:173. doi: 10.1089/089277903321618743. [DOI] [PubMed] [Google Scholar]
- 19.Sidhu H, Allison MJ, Chow JM, Clark A, Peck AB. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J Urol. 2001;166:1487. [PubMed] [Google Scholar]